Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Coeptis Therapeutics Inc.
| Metric | Coeptis Therapeutics Inc. Healthcare |
|---|---|
| Quality Score | 45 / 100 |
| Revenue (latest) | $75,000 |
| Net income (latest) | −$13M |
| Operating margin | −18977.4% |
| Net margin | −17932.4% |
| Return on equity | −572.2% |
| Return on assets | −198.8% |
| Return on capital (ROCE) | −355.8% |
| Debt / equity | 1.88× |
| Revenue growth (YoY) | 143.8% |
| Altman Z″ (distress) | -27.42 |
| Accruals / assets | −132.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.